249 related articles for article (PubMed ID: 8710741)
41. Physiological and cytotoxic effects of Ca(2+) ionophores on Caco-2 paracellular permeability: relationship of 45Ca(2+) efflux to 51 Cr release.
Rutten MJ; Cogburn JN; Schasteen CS; Solomon T
Pharmacology; 1991; 42(3):156-68. PubMed ID: 1905412
[TBL] [Abstract][Full Text] [Related]
42. Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: correlation with membrane transport and transepithelial secretion.
Lowes S; Simmons NL
Pflugers Arch; 2001 Nov; 443(2):265-73. PubMed ID: 11713653
[TBL] [Abstract][Full Text] [Related]
43. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
45. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
46. Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers.
Torii M; Takiguchi Y; Izumi M; Fukushima T; Yokota M
Int J Pharm; 2002 Feb; 233(1-2):253-6. PubMed ID: 11897429
[TBL] [Abstract][Full Text] [Related]
47. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
48. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
49. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
50. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model.
Seeballuck F; Lawless E; Ashford MB; O'Driscoll CM
Pharm Res; 2004 Dec; 21(12):2320-6. PubMed ID: 15648264
[TBL] [Abstract][Full Text] [Related]
51. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
52. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
53. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells.
Schipper NG; Vårum KM; Artursson P
Pharm Res; 1996 Nov; 13(11):1686-92. PubMed ID: 8956335
[TBL] [Abstract][Full Text] [Related]
54. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers.
Lim SL; Lim LY
Int J Pharm; 2006 Jan; 307(1):42-50. PubMed ID: 16260103
[TBL] [Abstract][Full Text] [Related]
55. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
[TBL] [Abstract][Full Text] [Related]
56. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
[TBL] [Abstract][Full Text] [Related]
57. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.
Feighery LM; Cochrane SW; Quinn T; Baird AW; O'Toole D; Owens SE; O'Donoghue D; Mrsny RJ; Brayden DJ
Pharm Res; 2008 Jun; 25(6):1377-86. PubMed ID: 18163202
[TBL] [Abstract][Full Text] [Related]
58. Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro.
Cornaire G; Woodley JF; Saivin S; Legendre JY; Decourt S; Cloarec A; Houin G
Arzneimittelforschung; 2000 Jun; 50(6):576-9. PubMed ID: 10918954
[TBL] [Abstract][Full Text] [Related]
59. Transport of peptidomimetic thrombin inhibitors with a 3-amidino-phenylalanine structure: permeability and efflux mechanism in monolayers of a human intestinal cell line (Caco-2).
Kamm W; Hauptmann J; Behrens I; Stürzebecher J; Dullweber F; Gohlke H; Stubbs M; Klebe G; Kissel T
Pharm Res; 2001 Aug; 18(8):1110-8. PubMed ID: 11587481
[TBL] [Abstract][Full Text] [Related]
60. MRP2-mediated transport of etoposide in MDCKII MRP2 cells is unaffected by commonly used non-ionic surfactants.
Nielsen S; Westerhoff AM; Gé LG; Carlsen KL; Pedersen MDL; Nielsen CU
Int J Pharm; 2019 Jun; 565():306-315. PubMed ID: 31085259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
